Sfoglia per AUTORE
BANCOS I
Collezione ASL Torino 4
Items : 2
Corrigendum: Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study. in Frontiers in endocrinology / Front Endocrinol (Lausanne). 2022 Apr 27;13:899616. doi: 10.3389/fendo.2022.899616. eCollection 2022
2022
ASL Torino 4
AOU San Luigi di Orbassano
ASL Torino 4
AOU San Luigi di Orbassano
Terzolo M; Mariash CN; Gordon MB; Kerr JM; Kargi AY; Feelders RA; Bancos I; Pivonello R; Ellison N; Moraitis AG;
First randomized trial on adjuvant mitotane in adrenocortical carcinoma patients: The Adjuvo study in Journal of Clinical Oncology
2022
ASL Torino 4
ASL Torino 4
Berruti A; Fassnacht M; Libè R; Lacroix A; Kastelan D; Haak H; Arlt W; Decoudier B; Lasolle H; Bancos I; Quinkler M; Barisson Villares Fragoso MC; Canu L; Puglisi S; Bourdeau I; Baudin E; Berchialla P; Beuschlein F; Bertherat J; Terzolo M;